PJ Taylor, CH Tai, ME Franklin… - Clinical biochemistry, 2011 - Elsevier Therapeutic drug monitoring of critical dose immunosuppressant drugs is established clinical practice and there are similar good reasons to monitor antiretrovirals. The aim of this article is to review the recent literature (last five years), with particular reference to the use of liquid ... Cited by 1 - Related articles - All 4 versions
M Gerin, N Mahlaoui, C Elie… - … Drug Monitoring, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... Related articles - All 4 versions
R Nieuwlaat, SJ Connolly… - Implementation …, 2011 - implementationscience.com We conducted a decision-maker-researcher partnership systematic review. Studies from our previous review were included, and new studies were sought until January 2010 in MEDLINE, EMBASE, Evidence-Based Medicine Reviews, and Inspec databases. ... Cached
T van Gelder - Clinical Pharmacology & Therapeutics, 2011 - nature.com For the calcineurin inhibitors (CNIs) and mammalian target of rapamycin (mTOR) inhibitors, the implementation of therapeutic drug monitoring (TDM) is based on the demonstration of a high between-patient variability in the pharmacokinetics of the drug and a concentration-effect ... Cited by 1
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
